Objective: To establish a new method for rapid diagnosis of late infantile
neuronal ceroid lipofuscinosis (LINCL, CLN2) using specific polyclonal anti
bodies against the CLN2 gene product. Methods: Cells and tissues were obtai
ned from five patients with LINCL, two with variant type NCL, three with ot
her lysosomal storage diseases, and eight control subjects. Two antibodies
were raised against N- and C-terminal peptide fragments of the normal produ
ct of the CLN2 gene. The authors examined the possibility of diagnosis of L
INCL with immunostaining and immunoblotting using specific antibodies made
of the recently identified defective gene in LINCL. Results: Immunoreactivi
ty with these antibodies showed the absence or marked reduction of CLN2 imm
unoreactivity in the lymphocytes, lymphoblasts, and fibroblasts of all five
patients with LINCL examined. Conclusions: These results indicate the usef
ulness of this diagnostic method based on the changes in CLN2 immunoreactiv
ity. This relatively simple, specific, and cost-effective method is a promi
sing diagnostic tool for this disease, although additional studies are nece
ssary.